新京报贝壳财经讯12月30日，明德生物（002932）发布公告称，公司已与蓝帆医疗（002382）签订《股 权收购意向协议》，计划以现金形式收购武汉必凯尔救助用品有限公司(简称"必凯尔")的全部股权。此 次交易预计将构成重大资产重组，但不涉及重组上市，也无需发行股份。交易完成后，必凯尔将成为明 德生物的全资子公司。必凯尔是国内较早引入国际第一急救(FirstAid)理念和技术的企业，其核心业务为 急救包，并在此基础上全面拓展应急装备、应急单品及应急服务等应急救护相关业务。 ...

Group 1 - The National Development and Reform Commission (NDRC) and the Ministry of Finance have issued a notice regarding a 625 billion yuan special government bond plan to support the consumption of old goods in 2026 [2] - The new policy on individual sales of housing capital gains tax states that individuals selling homes purchased within two years will pay a 3% tax, while those selling homes purchased for over two years will be exempt from the tax starting January 1, 2026 [2] - The Ministry of Industry and Information Technology (MIIT) has released a digital transformation implementation plan for the automotive industry, aiming for significant integration of digital technologies by 2027 and achieving a high level of overall digital development by 2030 [3] Group 2 - Changjiang Electric Power announced a cash dividend distribution plan, proposing a payout of 2.1 yuan per 10 shares, totaling approximately 5.138 billion yuan [4] - Dongjie Intelligent has decided to terminate its major asset restructuring plan involving the acquisition of a controlling stake in Aobo (Beijing) Intelligent Technology, with no adverse impact on its business operations [4] - Mingde Biological has signed an agreement to acquire 100% of Wuhan Bikaier Rescue Supplies Co., which will enhance its emergency medical service capabilities [4] Group 3 - Salt Lake Co. plans to acquire a 51% stake in Wukuang Salt Lake Co. for 4.605 billion yuan, which will make Wukuang a subsidiary and included in the consolidated financial statements [9] - Guotou Zhonglu intends to purchase 100% of China Electronic Engineering Design Institute for 6.026 billion yuan through a share issuance, expanding its business into the electronic information industry [9] - The report from CITIC Securities indicates a positive outlook for domestic semiconductor silicon wafer companies due to increasing demand driven by capital expenditure and technological advancements [10]

重要新闻提示 2026年第一批625亿元超长期特别国债支持消费品以旧换新资金计划已提前下达 两部门发布个人销售住房增值税政策：不满2年按3%全额缴纳，2年以上免征 长江电力：拟每10股派2.1元，共派发现金红利51.38亿元 今日提示 创业板新股新广益（301687）、北交所新股蘅东光（920045）今日上市 12月PMI数据今日发布 今日有260亿元7天期逆回购到期 国家发展改革委今日召开12月份新闻发布会 宇树科技全国首店今日在北京京东MALL开业 财经新闻 1. 中央农村工作会议12月29日至30日在北京召开。会议分析当前"三农"工作面临的形势和挑战，部署 2026年"三农"工作。从产业视角看，本次会议围绕推动粮食品种培优和品质提升、发展农业新质生产 力、培育壮大县域富民产业等核心议题，提出了一系列具有针对性的新要求与新举措，为加快推进农业 农村现代化、建设农业强国指明了产业发展的实践路径。 2. 商务部、国家发展改革委等八部门办公厅日前印发《2026年汽车以旧换新补贴实施细则》。其中提 出，2026年，对个人消费者报废2013年6月30日前注册登记的汽油乘用车、2015年6月30日前注册登记的 柴油及 ...

【 导读】 明德生物 拟 现金收购武汉必凯尔100%股权 中国基金报记者 若文 12月30日， 明德生物公告称，公司与蓝帆医疗签署《股权收购意向协议》，拟以现金方式收购武汉必凯尔救助用品有限公司 （ 以下简称 武汉必凯尔 ） 100%股权。 明德生物 预计，本次交易构成重大资产重组，不构成重组上市，不涉及发行股份。交易完成后，标的公司将成为公司的全资子公司。 拟收购蓝帆医疗旗下急救包公司 但与之形成鲜明对比的是，期内公司 应收账款余额 高达 6.53亿元， 远超营收规模。 拉长时间轴不难发现，昔日"检测王" 在疫情退潮后 面临明显的回款压力。 2022年，主营诊断试剂的明德生物营业收入 一度 膨胀到105.30亿元， 彼时公司 应收账款达到25.60亿元，占总资产比例为27.85%。 此后，随着行业环境变化，公司营收在2023年、2024年分别回落至7.50亿元、3.50亿元，同比下滑92.88%和53.30%。 公开资料显示， 武汉必凯尔成立于2010年，由蓝帆医疗100%持股。是国内较早引入国际急救（First Aid）理念的企业。注册资本约 1845万元，由蓝帆医疗100%持股。公司主营业务围绕急救包展 ...

【导读】明德生物拟现金收购武汉必凯尔100%股权 12月30日，明德生物公告称，公司与蓝帆医疗签署《股权收购意向协议》，拟以现金方式收购武汉必凯尔救助用品有限公司（以下简称武汉必凯尔） 100%股权。 明德生物预计，本次交易构成重大资产重组，不构成重组上市，不涉及发行股份。交易完成后，标的公司将成为公司的全资子公司。 拟收购蓝帆医疗旗下急救包公司 2022年，主营诊断试剂的明德生物营业收入一度膨胀到105.30亿元，彼时公司应收账款达到25.60亿元，占总资产比例为27.85%。 公开资料显示，武汉必凯尔成立于2010年，由蓝帆医疗100%持股。是国内较早引入国际急救（First Aid）理念的企业。注册资本约1845万元，由蓝帆医疗 100%持股。公司主营业务围绕急救包展开，涵盖应急装备、应急单品和应急服务。 明德生物表示，本次交易是公司基于聚焦急危重症业务板块战略发展需求所做出的重要布局。标的公司作为应急防护领域的领先企业，长期服务于海内外 高质量工业端客户，并积极向家庭消费端延伸。 从协同角度看，明德生物强调双方在产品线与客户群上具备显著互补性：公司现有急危重症智慧诊断业务主要面向医疗机构，而标的公司在 ...

Company Announcements - Tianpu Co., Ltd. has seen a cumulative increase of 718.39% in stock price from August 22 to December 30, leading to a suspension for verification starting December 31, 2025 [1] - Dongjie Intelligent has terminated its major asset restructuring plan and will resume trading on December 31, 2025 [2] - Zijin Mining expects a net profit increase of 59%-62% for 2025, with significant increases in the sales prices of gold, copper, and silver [2] - Jinpan Technology signed a contract for an overseas data center project worth approximately 696 million yuan [3] - Yanhai Co., Ltd. plans to acquire 51% of Wenkang Salt Lake for 4.605 billion yuan to enhance its salt lake industry base [5] - Shengxin Lithium Energy intends to acquire 30% of Qicheng Mining for 2.08 billion yuan, which is developing a lithium mine with an annual capacity of 3 million tons [7] - Mingde Bio plans to acquire 100% of Wuhan Bikaier Rescue Supplies Co., Ltd. in a significant asset restructuring [8] - Guotou Zhonglu plans to issue shares to acquire 100% of China Electronics Engineering Design Institute for 6.026 billion yuan [9] - Zhaoxing Co., Ltd. plans to invest 1.53 billion yuan in intelligent robotics and high-precision components for automotive applications [10] Stock Movements - Chaojie Co., Ltd. reported a reduction of 3.00% in shares by its controlling shareholder from November 25 to December 29, 2025 [6] - Five Continents New Spring's third-largest shareholder reduced holdings by 2.73% from November 3 to December 29, 2025 [13] - Zhongju Gaoxin plans to repurchase shares worth 300 million to 600 million yuan for capital reduction [20] Contracts and Projects - Zhejiang Construction signed an 18 billion yuan construction contract for a campus project [23] - Shen Si Electronics won a 199.8 million yuan project for low-altitude flight management services in Jinan [24] - Wangfujing signed a contract for a duty-free project at Beijing Capital International Airport, with a minimum operating fee of 113 million yuan [25] Investments and Financing - Tianyuan Co., Ltd. plans to invest 1.483 billion yuan in a titanium dioxide project [15] - Zhongke Co., Ltd. plans to invest 1.741 billion yuan in an expansion project for lead-zinc mining [16] - Zongheng Co., Ltd. plans to raise up to 548 million yuan for drone systems and AI technology projects [26]

又有上市公司筹划重大资产重组。 明德生物（002932）12月30日晚间公告，公司与蓝帆医疗股份有限公司（简称"蓝帆医疗"）签署《股权收购意向协议》，双方就公 司以现金方式收购武汉必凯尔救助用品有限公司（简称"标的公司"）100%股权的交易达成框架性意向，并明确双方后续就本次交 易进行收购工作安排以及签署正式收购协议等事项。本次交易完成后，标的公司将成为公司的全资子公司。 据了解，标的公司是较早引入国际第一急救（FirstAid）理念和技术的企业，主要从事以急救包为核心，全面布局应急装备、应急 单品和应急服务的应急救护业务。 而明德生物成立于2008年，坐落于国家生物产业基地——武汉光谷生物城，是一家专注于体外诊断产品自主研发、生产、销售， 提供基于五大中心的医疗信息化整体解决方案和第三方医学检验服务的国家高新技术企业。经过多年技术积累，公司构建了以10 大技术平台为支撑的丰富产品矩阵，涵盖免疫、血气、分子诊断产品线，形成以即时、精准诊断产品为基石，以急危重症信息化 系统为桥梁的区域协同救治型智慧诊断整体解决方案，实现院前、院中、院后全流程布局。目前业务已覆盖全国30个省、直辖 市、自治区的7500家医疗机构 ...

又有上市公司筹划重大资产重组。 明德生物(002932)12月30日晚间公告，公司与蓝帆医疗股份有限公司（简称"蓝帆医疗"）签署《股权收购意向协议》，双方就公司 以现金方式收购武汉必凯尔救助用品有限公司（简称"标的公司"）100%股权的交易达成框架性意向，并明确双方后续就本次交易 进行收购工作安排以及签署正式收购协议等事项。本次交易完成后，标的公司将成为公司的全资子公司。 公告显示，根据初步测算，本次交易预计构成《上市公司重大资产重组管理办法》规定的重大资产重组。本次交易拟采用现金方 式，不构成重组上市，不涉及上市公司发行股份。本次交易不构成关联交易，也不会导致上市公司控股股东和实际控制人变更。 本次交易公司将按照相关规定履行相关程序，编制、披露相关文件。 据了解，标的公司是较早引入国际第一急救（FirstAid）理念和技术的企业，主要从事以急救包为核心，全面布局应急装备、应急 单品和应急服务的应急救护业务。 明德生物表示，本次交易是公司基于聚焦急危重症业务板块战略发展需求所做出的重要布局。标的公司作为应急防护领域的领先 企业，长期服务于海内外高质量工业端客户，并积极向家庭消费端延伸。公司与标的公司在产品线与 ...

Group 1 - Deeply Housing A's controlling shareholder has decided to terminate the agreement to transfer 7.07% of the company's shares to Dongfang Asset, which will not lead to any changes in the controlling shareholder or actual controller of the company [1] - Wuzhou New Spring's controlling shareholder has reduced its stake by 2.73%, with a total of 9.99 million shares sold, and confirmed that there are no undisclosed significant matters affecting the company's stock price [2] - Baiwei Storage's subsidiary plans to acquire 380,066 shares of Niu Xin Semiconductor for 20 million yuan, representing 0.8446% of its total share capital, focusing on high-speed transmission and interconnection technology [3] Group 2 - Zhaofeng Co. plans to change part of its raised funds to invest in the industrialization of embodied intelligent robots and high-end precision components for automotive intelligent driving, with a total investment of 153 million yuan [4] - Tianpu Co. has seen its stock price increase by 718.39% from August 22 to December 30, leading to a suspension for verification due to significant deviation from the company's fundamentals [5] - Jingce Electronics has signed contracts to sell semiconductor front-end detection equipment worth a total of 571 million yuan [6] Group 3 - Jiamei Packaging has announced that it may apply for a suspension of trading if its stock price continues to rise abnormally, despite no significant changes in its fundamentals [7] - Zijin Mining expects a net profit of approximately 51 billion to 52 billion yuan for 2025, an increase of 59%-62% year-on-year, driven by rising sales prices of gold, copper, and silver [8][9] - Mingde Bio plans to acquire 100% equity of Wuhan Bikaier Rescue Supplies Co., which is expected to constitute a major asset restructuring [10] Group 4 - Shengxin Lithium Energy intends to acquire a 30% stake in Qicheng Mining for 2.08 billion yuan, with the latter's lithium mine development progressing [11] - Chaojie Co.'s controlling shareholder has completed a share reduction plan, reducing its stake to 45.37% without affecting the company's control [12] - Shichuang Energy's actual controller has undergone a change in indirect shareholding due to a divorce, but this will not affect the company's control [13] Group 5 - Yilake Co. plans to acquire 51% of Wuku Salt Lake for 4.605 billion yuan, which will become a subsidiary of the company upon completion of the transaction [14] - Various companies have reported significant contract wins, including Changjiang Electric Power's cash dividend distribution and multiple projects won by China Western Electric [18]

又有上市公司筹划重大资产重组。 明德生物（002932）12月30日晚间公告，公司与蓝帆医疗股份有限公司（简称"蓝帆医疗"）签署《股权收购意向协 议》，双方就公司以现金方式收购武汉必凯尔救助用品有限公司（简称"标的公司"）100%股权的交易达成框架性意 向，并明确双方后续就本次交易进行收购工作安排以及签署正式收购协议等事项。本次交易完成后，标的公司将成为 公司的全资子公司。 公告显示，根据初步测算，本次交易预计构成《上市公司重大资产重组管理办法》规定的重大资产重组。 本次交易拟 采用现金方式，不构成重组上市，不涉及上市公司发行股份。本次交易不构成关联交易，也不会导致上市公司控股股 东和实际控制人变更。本次交易公司将按照相关规定履行相关程序，编制、披露相关文件。 据了解，标的公司是较早引入国际第一急救（FirstAid）理念和技术的企业，主要从事以急救包为核心，全面布局应急 装备、应急单品和应急服务的应急救护业务。 而明德生物成立于2008年，坐落于国家生物产业基地——武汉光谷生物城，是一家专注于体外诊断产品自主研发、生 产、销售，提供基于五大中心的医疗信息化整体解决方案和第三方医学检验服务的国家高新技术企业。 ...